Induction of Apoptosis by the Garlic-Derived Compound S-Allylmercaptocysteine (SAMC) Is Associated with Microtubule Depolymerization and c-Jun NH2-Terminal Kinase 1 Activation

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6825-6837

  Xiao, Danhua ^a   Pinto, John T ^b   Soh, Jae Won ^a   Deguchi, Atsuko ^a   Gundersen, Gregg G ^a   Palazzo, Alexander F ^a   Yoon, Jung Taek ^a   Shirin, Haim ^c   Weinstein, I Bernard ^a  

^a Columbia University ^*  (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CYSTEINE DERIVATIVE; GARLIC EXTRACT; MERCAPTOCYSTEINE; PHOSPHOTRANSFERASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CENTROSOME; CYTOSKELETON; DEPOLYMERIZATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GARLIC; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERPHASE; MICROTUBULE; MITOSIS SPINDLE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BINDING SITES; CASPASE 3; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CENTROSOME; COLONIC NEOPLASMS; CYSTEINE; ENZYME ACTIVATION; ENZYME INHIBITORS; GOLGI APPARATUS; HUMANS; MICE; MICROTUBULES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUBULIN;

EID: 0142188703     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pinto, J. T., Lapsia, S., Shah, A., Santiago, H., and Kim, G. Antiproliferative effects of garlic-derived and other allium related compounds. In: American Institute for Cancer Research (eds.), Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals, pp. 83-106. New York: Kluwer Academic/Plenum Publishers, 2000.
2. Shirin, H., Pinto, J. T., Kawabata, Y., Soh, J. W., Dolohery, T., Moss, S. F., Murty, V., Rivlin, R. S., Holt, P. R., and Weinstein, I. B. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res., 61: 725-731, 2001.
3. Wilson, L., and Jordan, M. A. Microtubule dynamics: taking aim at a moving target. Chem. Biol., 2: 569-573, 1995.
4. Wilson, L., and Jordan, M. A. Pharmacological probes of microtubule function. In: J. S. Hyams and C. W. Lloyd (eds.), Microtubules, pp. 59-83. New York: Wiley-Liss, 1994.
5. Chen, N., She, Q. B., Bode, A. M., and Dong, Z. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells. Cancer Res., 62: 1300-1304, 2002.
6. Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., and Weinstein, I. B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res., 8: 893-903, 2002.
7. 2-terminal kinase 1. Clin. Cancer Res., 6: 4136-4141, 2000.
8. Dan, C., Nath, N., Liberto, M., and Minden, A. PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol. Cell. Biol., 22: 567-577, 2002.
9. Jiang, W., and Hunter, T. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP. BioTechniques, 24: 348-354, 1998.
10. Yoon, J. T., Palazzo, A. F., Xiao, D., Delohery, T. M., Warburton, P. E., Bruce, J. N., Thompson, W. J., Sperl, G., Whitehead, C., Fetter, J., Pamukcu, R., Gundersen, G. G., and Weinstein, I. B. CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells. Mol. Cancer Ther., 1: 393-404, 2002.
11. Kilmartin, J. V., Wright, B., and Milstein, C. Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line. J. Cell Biol., 93: 576-582, 1982.
12. Wang, T. H., Wang, H. S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalascna, J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem., 273: 4928-4936, 1998.
13. Logan, T. J., Jordan, K. L., and Hall, D. Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor. Mol. Biol. Cell, 5: 667-678, 1994.
14. Thyberg, J., and Moskalewski, S. Role of microtubules in the organization of the Golgi complex. Exp. Cell Res., 246: 263-279, 1999.
15. Keates, R. A., and Mason, G. B. Inhibition of microtubule polymerization by the tubulin-colchicine complex: inhibition of spontaneous assembly. Can. J. Biochem., 59: 361-370, 1981.
16. Schiff, P. B., and Horwitz, S. B. Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate of microtubule-associated proteins. Biochemistry, 20: 3247-3252, 1981.
17. Jordan, A., Hadfield, J. A., Lawrence, N. J., and McGown, A. T. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev., 18: 259-296, 1998.
18. Jiang, J. D., Denner, L., Ling, Y. H., Li, J. N., Davis, A., Wang, Y., Li, Y., Roboz, J., Wang, L. G., Perez-Soler, R., Marcelli, M., Bekesi, G., and Holland, J. F. Double blockade of cell cycle at G1-S transition and M phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. Cancer Res., 62: 6080-6088, 2002.
19. Bennett, B. L., Sasaki, D. T., Murray, B. W. O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., and Anderson, D. W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA, 98: 13681-13686, 2001.
20. Han, Z., Boyle, D. L., Chang, L., Bonnett, B., Karin, M., Yang, L., Manning, A. M., and Firestein, G. S. c-Jun N-terminal kinase is acquired for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Investig., 108: 73-81, 2001.
21. 2/M cell cycle arrest in HT 29 cells. Toxicology, 175: 123-142, 2002.
22. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Wash. DC), 281: 1312-1316, 1998.
23. 2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res., 60: 5995-6000, 2000.
24. Hsing, A. W., Chokkalingam, A. P., Gao, Y. T., Madigan, M. P., Deng, J., Gridley, G., and Fraumeni, J. F., Jr. Allium vegetables and risk of prostate cancer: a population-based study. J. Natl. Cancer Inst. (Bethesda), 94: 1648-1651, 2002.
25. Pinto, J. T., Qiao, C., Xing, J., Rivlin, R. S., Protomastro, M. L., Weissler, M. L., Tao, Y., Thaler, H., and Heston, W. D. Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am. J. Clin. Nutr., 66: 398-405, 1997.
26. Sigounas, G., Hooker, J. L., Li, W., Anagnostou, A., and Steiner, M. S-allylmercaplocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines. Nutr. Cancer, 28: 153-159, 1997.
27. Chandburi, A. R., Khan, I. A., and Luduena, R. F. Detection of disulfide bonds in bovine brain tubulin and their role in protein folding and microtubule assembly in vitro: a novel disulfide detection approach. Biochemistry, 40: 8834-8841, 2001.
28. Luduena, R. F., and Roach, M. C. Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. Pharmacol. Ther., 49: 133-152, 1991.
29. Legault, J., Gaulin, J. F., Mounetou, E., Bolduc, S., Lacroix, J., Poyet, P., and Gaudreault, R. C. Microtubule disruption induced in vivo by alkylation of β-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents. Cancer Res., 60: 985-992, 2000.
30. Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T. C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., Rosen, T., Timmermans, P. B., and Beckmann, H. Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc. Natl. Acad. Sci. USA, 96: 5686-5691, 1999.
31. Chen, J. G., and Horwitz, S. B. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res., 62: 1935-1938, 2002.
32. Hirsch, K., Danilenko, M., Giat, J., Miron, T., Rabinkov, A., Wilchek, M., Mirelman, D., Levy, J., and Sharoni, Y. Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr. Cancer, 38: 245-254, 2000.
33. Lawson, L. D., Ransom, D. K., and Hughes, B. G. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb. Res., 65: 141-156, 1992.
34. Lawson, L. D., and Wang, Z. J. Pre-hepatic fate of the organosulfur compounds derived from garlic (Allium sativum). Planta Med., 59 (Suppl.): A688-A689, 1993.
35. Rabinkov, A., Miron, T., Konstantinovski, L., Wilchek, M., Mirelman, D., and Weiner, L. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim. Biophys. Acta, 1379: 233-244, 1998.
36. Rabinkov, A., Miron, T., Mirelman, D., Wilchek, M., Glozman, S., Yavin, E., and Weiner, L. S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim. Biophys. Acta, 1499: 144-153, 2000.
37. Frantz, D. J., Hughes, B. G., Nelson, D. R., Murray, B. K., and Christensen, M. J. Cell cycle arrest and differential gene expression in HT-29 cells exposed to an aqueous garlic extract. Nutr. Cancer, 38: 255-264, 2000.
38. Munday, R., and Munday, C. M. Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinone reductase and glutathione transferase in rat tissues. Nutr. Cancer, 40: 205-210, 2001.
39. Lee, E. S., Steiner, M., and Lin, R. Thioallyl compounds: potent inhibitors of cell proliferation. Biochim. Biophys. Acta, 1221: 73-77, 1994.
40. Sundaram, S. G., and Milner, J. A. Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochim. Biophys. Acta, 1315: 15-20, 1996.
41. Welch, C., Wuarin, L., and Sidell, N. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Lett., 63: 211-219, 1992.
42. Takeyama, H., Hoon, D. S., Saxton, R. E., Morton, D. L., and Irie, R. F. Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine. Oncology, 50: 63-69, 1993.
43. Nagae, S., Ushijima, M., Hatono, S., Imai, J., Kasuga, S., Matsuura, H., Itakura, Y., and Higashi, Y. Pharmacokinetics of the garlic compound S-allylcysteine. Planta Med., 60: 214-217, 1994.
44. Sumioka, I., Matsura, T., Kasuga, S., Itakura, Y., and Yamada, K. Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver in mice. Jpn. J. Pharmacol., 78: 199-207, 1998.
45. Sumioka, I., Matsura, T., and Yamada, K. Therapeutic effect of S-allylmercaptocysteine on acetaminophen-induced liver injury in mice. Eur. J. Pharmacol., 433(2-3): 177-185, 2001.
46. Gorman, A. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., and Ceccatelli, S. Cytochrome c release and caspase-3 activation during colchicne-induced apoptosis of cerebellar granule cells. Eur. J. Neurosci., 11: 1067-1072, 1999.
47. Wang, T. H., Popp, D. M., Wang, H. S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., and Wimalasena, J. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J. Biol. Chem., 274: 8208-8216, 1999.
48. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem., 272: 10110-10116, 1997.
49. Wojtaszek, P. A., Heasley, L. E., Siriwardana, G., and Berl, T. Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J. Biol. Chem., 273: 800-804, 1998.
50. 2-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 62: 1343-1348, 2002.
51. 2-terminal kinase-2-deficient mice. Cancer Res., 61: 3908-3912, 2001.
52. Reszka, A. A., Seger, R., Diltz, C. D., Krebs, E. G., and Fischer, E. H. Association of mitogen-activated protein kinase with the microtubule cylosketeton. Proc. Natl. Acad. Sci. USA, 92: 8881-8885, 1995.
53. Nagata, K., Puls, A., Futter, C., Aspenstrom, P., Schaefer, E., Nakata, T., Hirokawa, N., and Hall, A. The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J., 17: 149-158, 1998.
54. Ling, Y. H., Tornos, C., and Perez-Soler, R. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J. Biol. Chem., 273: 18984-18991, 1998.